MedTrace Logo

Performance and Safety of Semical Dermal Fillers in Facial Rejuvenation

NCT07160777 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2025-09-08

No results posted yet for this study

Summary

The aim of the study is to verify safety and performance of Semical dermal fillers according to real-world data.

Conditions

  • Facial Aging
  • Skin Rejuvenation
  • Volume Defects in the Mid-face
  • Lip Augmentation and Correction of Perioral Rhytids
  • Marionette Lines
  • Nasolabial Fold Correction
  • Periorbital Wrinkles
  • Facial Wrinkles and Rhytides Reduction

Interventions

DEVICE

cross-linked hyaluronic acid

Semical Dermal Filler Fine Semical Dermal Filler Plus Semical Dermal Filler Ultra

DEVICE

Mesolifter

Stabilized hyaluronic acid with NONASEM Technology. Application with Multi-Aesthetic Point Technique (MAPs)

Sponsors & Collaborators

  • Semikal Technology

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07160777 on ClinicalTrials.gov